Drugs / Dimercaptosuccinic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07709871 | Aug 2026 → Jan 2029 expected | diabetic kidney disease | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dimercaptosuccinic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07709871 ↗ |
| Known as | DMSA | “oral dimercaptosuccinic acid (DMSA) capsules for lead removal” NCT07709871 ↗ |
| Route | Oral | “receive oral dimercaptosuccinic acid (DMSA) capsules” NCT07709871 ↗ |